A NEW GENERATION WHERE SCIENCE, NATURE, AND TECHNOLOGY MERGE.

We are eager to embark on this journey by uniting minds and developing groundbreaking answers to these areas, where science can truly shine.

A Bit About Us

KRTL Biotech Inc., a wholly owned subsidiary of KRTL Holding Group, Inc. (OTC: KRTL), is a research and development company that has obtained a Ministry of Food and Drug Safety (MFDS), formerly known as the Korea Food & Drug Administration (KFDA) approval for psilocybin and CBD research. KRTL Biotech is looking to collaborate and partner with universities and biotech companies to facilitate this venture.

Research and Development

Creating Strategic Partnerships

Unique Formulations

Global KRTL Brand

DRIVEN BY COLLABORATION

We at KRTL Biotech are looking to collaborate and partner with universities and biotech companies to facilitate this venture. 

We Take Pride in Our Numbers

300+

SCI (Science Citation Index) Research Papers

100+

Years of Experience

$1-2B

Potential Product Market

22

Countries World Wide

2

Global Footprint

(Countries)

Our Partners

ENTEXS_04_edited.png
Iron Sight 2 (1).png
Logo Juniper_edited_edited_edited_edited_edited.png

KRTL Global Affiliates

KRTL Biotech Inc. is focused on increasing its global footprint through its partners to create affiliations in multiple countries. What we are doing is establishing the KRTL brand, uniting the medical, psychological, and pharmaceutical world under a common goal, where ideas and technologies can be shared through affiliate companies.